The impact of translocations and gene fusions on cancer causation
暂无分享,去创建一个
[1] T. Haferlach,et al. Monitoring of minimal residual disease in acute myeloid leukemia , 2005, Cancer.
[2] J. Dick,et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.
[3] L. Ricci-Vitiani,et al. Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.
[4] G. Jenster,et al. TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer. , 2006, Cancer research.
[5] O. Kallioniemi,et al. TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming. , 2006, Cancer research.
[6] G. Parmigiani,et al. The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.
[7] R. Henrique,et al. TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions. , 2006, Neoplasia.
[8] J. Rowley,et al. Chromatin structural elements and chromosomal translocations in leukemia. , 2006, DNA repair.
[9] L. Povirk. Biochemical mechanisms of chromosomal translocations resulting from DNA double-strand breaks. , 2006, DNA repair.
[10] I. Panagopoulos,et al. Confirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancer. , 2006, Genes, chromosomes & cancer.
[11] Michael Ittmann,et al. Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer. , 2006, Cancer research.
[12] J. Tchinda,et al. TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. , 2006, Cancer research.
[13] Nicolò Riggi,et al. Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma. , 2006, Cancer research.
[14] T. Triche,et al. Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas. , 2006, Cancer research.
[15] I. Panagopoulos,et al. Confirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancer , 2006 .
[16] Thomas Cremer,et al. Chromosome territories--a functional nuclear landscape. , 2006, Current opinion in cell biology.
[17] A. Evans,et al. Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement. , 2006, Neoplasia.
[18] Farin Kamangar,et al. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] M. Lieber,et al. DNA structures at chromosomal translocation sites. , 2006, BioEssays : news and reviews in molecular, cellular and developmental biology.
[20] A. Tomaszewska,et al. [Chromosome instability syndromes]. , 2006, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.
[21] L. Szekely,et al. Molecular classification of mucoepidermoid carcinomas—Prognostic significance of the MECT1–MAML2 fusion oncogene , 2006, Genes, chromosomes & cancer.
[22] M. D. Boer,et al. The MLL recombinome of acute leukemias , 2006, Leukemia.
[23] Ioannis Panagopoulos,et al. Fusion of ETV6 with an intronic sequence of the BAZ2A gene in a paediatric pre‐B acute lymphoblastic leukaemia with a cryptic chromosome 12 rearrangement , 2006, British journal of haematology.
[24] M. Höglund,et al. A gene fusion network in human neoplasia , 2006, Oncogene.
[25] F. J. Novo,et al. Chromosome translocations in cancer: computational evidence for the random generation of double-strand breaks. , 2006, Trends in genetics : TIG.
[26] Arul M Chinnaiyan,et al. TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer. , 2006, Cancer research.
[27] S. Ogston,et al. Population-based demographic study of karyotypes in 1709 patients with adult Acute Myeloid Leukemia , 2006, Leukemia.
[28] C. Tribioli,et al. Leukemia with distinct phenotypes in transgenic mice expressing PML/RARα, PLZF/RARα or NPM/RARα , 2006, Oncogene.
[29] O. Heidenreich,et al. Targeting leukemic fusion proteins with small interfering RNAs: recent advances and therapeutic potentials , 2006, Acta Pharmacologica Sinica.
[30] F. Speleman,et al. Loss of the NPM1 gene in myeloid disorders with chromosome 5 rearrangements , 2006, Leukemia.
[31] Robert J. Marinelli,et al. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[32] K. Theil,et al. Frequencies and characterization of cytogenetically unrelated clones in various hematologic malignancies: seven years of experiences in a single institution. , 2006, Cancer genetics and cytogenetics.
[33] C. Antonescu. The role of genetic testing in soft tissue sarcoma , 2006, Histopathology.
[34] Recurrent Fusion of TMPRSS 2 and ETS Transcription Factor Genes in Prostate Cancer , 2006 .
[35] P. Aplan,et al. Causes of oncogenic chromosomal translocation. , 2006, Trends in genetics : TIG.
[36] Patrik Edén,et al. Molecular signatures in childhood acute leukemia and their correlations to expression patterns in normal hematopoietic subpopulations. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[37] Ralf Janknecht,et al. EWS-ETS oncoproteins: the linchpins of Ewing tumors. , 2005, Gene.
[38] A. Trumpp,et al. Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells. , 2005, Cancer research.
[39] F. Barr,et al. Chromosome translocations in sarcomas and the emergence of oncogenic transcription factors. , 2005, European journal of cancer.
[40] J. Tchinda,et al. Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer , 2005, Science.
[41] Michael R. Speicher,et al. The new cytogenetics: blurring the boundaries with molecular biology , 2005, Nature Reviews Genetics.
[42] A. Poustka,et al. Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue. , 2005, Cancer research.
[43] J. Dick,et al. Cancer stem cells: lessons from leukemia. , 2005, Trends in cell biology.
[44] B. Johansson,et al. Prevalence estimates of recurrent balanced cytogenetic aberrations and gene fusions in unselected patients with neoplastic disorders , 2005, Genes, chromosomes & cancer.
[45] L. Kearney,et al. Molecular cytogenetics in haematological malignancy: current technology and future prospects , 2005, Chromosoma.
[46] T. Jacks,et al. Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer , 2005, Cell.
[47] S. Bohlander. ETV6: a versatile player in leukemogenesis. , 2005, Seminars in cancer biology.
[48] P. Sorensen,et al. ETV6-NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineages. , 2005, Seminars in cancer biology.
[49] K. Anderson,et al. Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia , 2005, Nature Medicine.
[50] D. Pinkel,et al. Array comparative genomic hybridization and its applications in cancer , 2005, Nature Genetics.
[51] J. Fletcher,et al. Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes , 2005, Oncogene.
[52] Tom Misteli,et al. Concepts in nuclear architecture , 2005, BioEssays : news and reviews in molecular, cellular and developmental biology.
[53] M. Segal,et al. DNA topoisomerase II in therapy-related acute promyelocytic leukemia. , 2005, The New England journal of medicine.
[54] D. Gilliland,et al. Leukaemia stem cells and the evolution of cancer-stem-cell research , 2005, Nature Reviews Cancer.
[55] Ralf Küppers,et al. Mechanisms of B-cell lymphoma pathogenesis , 2005, Nature Reviews Cancer.
[56] B. Druker,et al. Oncogenes and Tumor Suppressors (795 articles) , 2004 .
[57] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[58] R. Pieters,et al. Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cells. , 2005, Cancer research.
[59] R. Pieters,et al. Diagnostic tool for the identification of MLL rearrangements including unknown partner genes. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[60] W. Hiddemann,et al. Population-based age-specific incidences of cytogenetic subgroups of acute myeloid leukemia. , 2005, Haematologica.
[61] R. Henkelman,et al. Identification of human brain tumour initiating cells , 2004, Nature.
[62] F. Lo‐Coco,et al. A new complex rearrangement involving the ETV6, LOC115548, and MN1 genes in a case of acute myeloid leukemia , 2004, Genes, chromosomes & cancer.
[63] C. Antonescu,et al. Midline carcinoma of children and young adults with NUT rearrangement. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[64] A. Ferrando,et al. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia , 2004, Nature Genetics.
[65] K. Kinzler,et al. Cancer genes and the pathways they control , 2004, Nature Medicine.
[66] J. Fletcher,et al. Activation of the GLI oncogene through fusion with the beta-actin gene (ACTB) in a group of distinctive pericytic neoplasms: pericytoma with t(7;12). , 2004, The American journal of pathology.
[67] B. Johansson,et al. Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer , 2004, Nature Genetics.
[68] I. Yaniv,et al. The predictive potential of molecular detection in the nonmetastatic Ewing family of tumors , 2004, Cancer.
[69] T. Hubbard,et al. A census of human cancer genes , 2004, Nature Reviews Cancer.
[70] A. Barabasi,et al. Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.
[71] B. Johansson,et al. Clinical and biological importance of cytogenetic abnormalities in childhood and adult acute lymphoblastic leukemia , 2004, Annals of medicine.
[72] C. Bloomfield,et al. Cytogenetics in Acute Leukemia , 2022 .
[73] D. Gilliland,et al. CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy. , 2003, Blood.
[74] J. Radich,et al. Monitoring bcr-abl by polymerase chain reaction in the treatment of chronic myeloid leukemia , 2003, Current oncology reports.
[75] M. Greaves,et al. Origins of chromosome translocations in childhood leukaemia , 2003, Nature Reviews Cancer.
[76] Tom Misteli,et al. Spatial proximity of translocation-prone gene loci in human lymphomas , 2003, Nature Genetics.
[77] Jen-Fen Fu,et al. Identification of CBL, a proto‐oncogene at 11q23.3, as a novel MLL fusion partner in a patient with de novo acute myeloid leukemia , 2003, Genes, chromosomes & cancer.
[78] P. Meltzer,et al. Soft tissue sarcomas of adults: state of the translational science. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[79] Keara M. Lane,et al. Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21) , 2003, Genes, chromosomes & cancer.
[80] F. Pedeutour,et al. Genetics of dermatofibrosarcoma protuberans family of tumors: From ring chromosomes to tyrosine kinase inhibitor treatment , 2003, Genes, chromosomes & cancer.
[81] S. Morrison,et al. Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[82] M. Potter,et al. Lymphoma‐ and leukemia‐associated chromosomal translocations in healthy individuals , 2003, Genes, chromosomes & cancer.
[83] N. Nowak,et al. High-resolution analysis of genetic events in cancer cells using bacterial artificial chromosome arrays and comparative genome hybridization. , 2003, Advances in cancer research.
[84] D. Gilliland,et al. Genetics of myeloid leukemias. , 2003, Annual review of genomics and human genetics.
[85] B. Johansson,et al. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976–1993 and on 5098 unselected cases reported in the literature 1974–2001 , 2002, Leukemia.
[86] F. Bertucci,et al. Reciprocal translocations in breast tumor cell lines: Cloning of a t(3;20) that targets the FHIT gene , 2002, Genes, chromosomes & cancer.
[87] P. Pandolfi,et al. Reciprocal products of chromosomal translocations in human cancer pathogenesis: key players or innocent bystanders? , 2002, Trends in molecular medicine.
[88] P. Nowell. Tumor progression: a brief historical perspective. , 2002, Seminars in cancer biology.
[89] P. Pfeiffer,et al. Chromosomal aberrations: formation, identification and distribution. , 2002, Mutation research.
[90] L. Foroni,et al. Cytogenetics and molecular genetics of acute lymphoblastic leukemia. , 2002, Reviews in clinical and experimental hematology.
[91] M. Andersen,et al. Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia. , 2002, Blood.
[92] B. Johansson,et al. Cytogenetic and Molecular Genetic Evolution of Chronic Myeloid Leukemia , 2002, Acta Haematologica.
[93] J. Downing,et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. , 2002, Cancer cell.
[94] J. Downing,et al. Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia. , 2002, Cancer cell.
[95] J. Downing,et al. Expression of a conditional AML 1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t ( 8 ; 21 ) acute myeloid leukemia , 2002 .
[96] J. Rowley,et al. Chromosome translocations: dangerous liaisons revisited , 2001, Nature Reviews Cancer.
[97] P. A. Pérez-Mancera,et al. Selective destruction of tumor cells through specific inhibition of products resulting from chromosomal translocations. , 2001, Current cancer drug targets.
[98] J. Squire,et al. Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis. , 2001, Blood.
[99] M. Pierotti. Chromosomal rearrangements in thyroid carcinomas: a recombination or death dilemma. , 2001, Cancer letters.
[100] Alfons Meindl,et al. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25 , 2001, Oncogene.
[101] J. Melo,et al. The molecular biology of chronic myeloid leukemia. , 2000, Blood.
[102] M. Nikiforova,et al. Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells. , 2000, Science.
[103] M. K. Hibbard,et al. PLAG1 fusion oncogenes in lipoblastoma. , 2000, Cancer research.
[104] T. Flores,et al. The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice , 2000, Oncogene.
[105] H. Rabes,et al. Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[106] M. Caligiuri,et al. Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in acute myeloid leukemia. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[107] M. Leversha,et al. Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia. , 2000, Blood.
[108] V. Kroha,et al. The topological organization of chromosomes 9 and 22 in cell nuclei has a determinative role in the induction of t(9,22) translocations and in the pathogenesis of t(9,22) leukemias , 1999, Chromosoma.
[109] Lisa Garrett,et al. The fusion gene Cbfb-MYH11 blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukaemia , 1999, Nature Genetics.
[110] Ash A. Alizadeh,et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays , 1999, Nature Genetics.
[111] B. Johansson,et al. Cytogenetic polyclonality in hematologic malignancies , 1999, Genes, chromosomes & cancer.
[112] A. Parreira,et al. The Nuclear Topography of ABL, BCR, PML, and RAR Genes: Evidence for Gene Proximity in Specific Phases of the Cell Cycle and Stages of Hematopoietic Differentiation , 1999 .
[113] A. Parreira,et al. The nuclear topography of ABL, BCR, PML, and RARalpha genes: evidence for gene proximity in specific phases of the cell cycle and stages of hematopoietic differentiation. , 1999, Blood.
[114] A. Andrén-sandberg,et al. Cytogenetic analysis of pancreatic carcinomas: Intratumor heterogeneity and nonrandom pattern of chromosome aberrations , 1998, Genes, chromosomes & cancer.
[115] W. Kuo,et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays , 1998, Nature Genetics.
[116] A T Look,et al. Oncogenic transcription factors in the human acute leukemias. , 1997, Science.
[117] B. Johansson,et al. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia , 1997, Nature Genetics.
[118] K. Kas,et al. Promoter swapping between the genes for a novel zinc finger protein and β-catenin in pleiomorphic adenomas with t(3;8)(p21;q12) translocations , 1997, Nature Genetics.
[119] M. Caligiuri,et al. Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia. , 1996, Blood.
[120] B. Johansson,et al. Primary vs. secondary neoplasia‐associated chromosomal abnormalities—balanced rearrangements vs. genomic imbalances? , 1996, Genes, chromosomes & cancer.
[121] T. Rabbitts,et al. An Mll–AF9 Fusion Gene Made by Homologous Recombination Causes Acute Leukemia in Chimeric Mice: A Method to Create Fusion Oncogenes , 1996, Cell.
[122] N. Mandahl. Cytogenetics and molecular genetics of bone and soft tissue tumors. , 1996, Advances in cancer research.
[123] A. Pinchera,et al. Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident. , 1995, Cancer research.
[124] E. Macintyre,et al. Highly purified primitive hematopoietic stem cells are PML-RARA negative and generate nonclonal progenitors in acute promyelocytic leukemia. , 1995, Blood.
[125] T. Rabbitts,et al. Chromosomal translocations in human cancer , 1994, Nature.
[126] J. Rowley,et al. Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. , 1993, Blood.
[127] D. Baltimore,et al. E2A-Pbx1, the t(1;19) translocation protein of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice , 1993, Molecular and cellular biology.
[128] M. Santoro,et al. Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[129] R. Berger,et al. Two site-specific deletions and t(1;14) translocation restricted to human T-cell acute leukemias disrupt the 5' part of the tal-1 gene. , 1991, Oncogene.
[130] A. Elefanty,et al. bcr‐abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice. , 1990, The EMBO journal.
[131] G. Jenster,et al. Acute leukaemia in bcr/abl transgenic mice , 1990, Nature.
[132] G. Daley,et al. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. , 1990, Science.
[133] F. Mitelman,et al. Primary chromosome abnormalities in human neoplasia. , 1989, Advances in cancer research.
[134] F. Mitelman,et al. Genetic convergence and divergence in tumor progression. , 1988, Cancer research.
[135] R. Palmiter,et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice , 1985, Nature.
[136] P. Nilsson,et al. Relation among occupational exposure to potential mutagenic/carcinogenic agents, clinical findings, and bone marrow chromosomes in acute nonlymphocytic leukemia. , 1978, Blood.
[137] P. Nowell. The clonal evolution of tumor cell populations. , 1976, Science.
[138] J. Rowley. A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining , 1973, Nature.
[139] F. Mitelman,et al. Tumor Etiology and Chromosome Pattern , 1972, Science.
[140] T. Caspersson,et al. Differential binding of alkylating fluorochromes in human chromosomes. , 1970, Experimental cell research.
[141] Amala Chaudhuri,et al. The chromosome number in man , 1963, Indian journal of pediatrics.
[142] P. Nowell,et al. A minute chromosome in human chronic granulocytic leukemia , 1960 .
[143] A. Levan. Chromosome studies on some human tumors and tissues of normal origin, grown in vivo and in vitro at the Sloan‐Kettering Institute , 1956, Cancer.
[144] S. Makino. FURTHER EVIDENCE FAVORING THE CONCEPT OF THE STEM CELL IN ASCITES TUMORS OF RATS , 1955, Annals of the New York Academy of Sciences.
[145] T. Hauschka. SECTION OF BIOLOGY*: CELL POPULATION STUDIES ON MOUSE ASCITES TUMORS† , 1953 .
[146] T. Hauschka. Cell population studies on mouse ascites tumors. , 1953, Transactions of the New York Academy of Sciences.
[147] Theodor Boveri. Zur Frage der Entstehung maligner Tumoren , 1914 .